Our findings demonstrate that knockdown of NAT10 or inhibition of its activity using small molecules NAT10‐2023 effectively suppresses tumor formation in spontaneous liver cancer models while mitigating liver damage associated with tumor progression. This evidence concerns the gene NAT10 and liver cancer.